“…Among them, the 4(3 H )-quinazolinone skeleton 2 is an important and privileged scaffold in medicinal chemistry; for instance, methaqualone 3 exhibits significant anticonvulsant activity; (−)-vasicinone 4 exhibits antitumor, bronchodilating, hypotensive, anthelmintic, and antianaphylactic activities; luotonin A 5 is a potential antitumor agent; and febrifugine 6 is a new lead compound as a type of antimalarial drug (Scheme 1). Consequently, increasing efforts have been devoted to the development of useful preparation methods for the generation of quinazolines, which mainly involve: (1) oxidative coupling of anilines bearing an ortho -functional group with different carbon and nitrogen sources, 2-halobenzenes or 2-halobenzyl amination-involved cyclization, 7 2-nitrobenzonitrile as a precursor to 2,3-dihydroquinazolin-4(1 H )-ones in a combined reduction/hydration/cyclocondensation sequence, 8 cyclization of o -acylaminobenzamides, condensation of aryl, alkyl and heteroaryl aldehydes through nucleophilic addition to imines or iminium ions and then a cyclization reaction with anthranilamide, amidation of 2-aminobenzonitrile, followed by oxidative ring closure and Ir, Ru, Pt, Pd-catalyzed heterocyclization of nitroarenes. 9 However, most of the reported methods suffer from harsh reaction conditions, tedious procedures, stoichiometric and large excess amounts of toxic oxidants, long reaction times, and frequently, low yields.…”